RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, 90403, USA.
RAND Corporation, 4570 Fifth Ave #600, Pittsburgh, PA, 15213, USA.
Prev Sci. 2020 Feb;21(2):245-255. doi: 10.1007/s11121-019-01082-6.
Costs of supporting prevention program implementation are not well known. This study estimates the societal costs of implementing CHOICE, a voluntary after-school alcohol and other drug prevention program for adolescents, in Boys and Girls Clubs (BGCs) across Southern California with and without an implementation support system called Getting To Outcomes© (GTO). This article uses micro-costing methods to estimate the cost of the CHOICE program and GTO support. Labor and expense data were obtained from logs kept by the BGC staff and by the GTO technical assistance (TA) staff, and staff time was valued based on Bureau of Labor Statistics estimates. From the societal perspective, the cost of implementing CHOICE at BGCs over the 2-year study period was $27 per attendee when CHOICE was offered by itself (all costs incurred by the BGCs) and $177 per attendee when CHOICE was offered with GTO implementation support ($67 cost to the BGCs; $110 to the entity funding GTO). These results were most sensitive to assumptions as to the number of times CHOICE was offered per year. Adding GTO implementation support to CHOICE increased the cost per attendee by approximately $150. For this additional cost, there was evidence that the CHOICE program was offered with more fidelity and offered more often after the 2-year intervention ended. If the long-term benefits of this better and continued implementation are found to exceed these additional costs, GTO could be an attractive structure to support evidence-based substance misuse prevention programs. Trial Registration. This project is registered at ClinicalTrials.gov with number NCT02135991 (URL: https://clinicaltrials.gov/show/NCT02135991). The trial was registered May 12, 2014.
支持预防计划实施的成本尚不清楚。本研究估计了在南加州的男孩女孩俱乐部（BGCs）中实施 CHOICE 计划的社会成本，CHOICE 是一项针对青少年的自愿课外酒精和其他药物预防计划，同时考虑了有无实施支持系统“实现成果”（GTO）。本文使用微观成本法来估计 CHOICE 计划和 GTO 支持的成本。劳动和费用数据是从 BGC 工作人员和 GTO 技术援助（TA）工作人员保留的日志中获得的，工作人员时间根据劳工统计局的估计进行估值。从社会角度来看，在 2 年的研究期间，在 BGC 中单独实施 CHOICE 的成本为每位参与者 27 美元（BGC 承担的所有费用），而在提供 GTO 实施支持的情况下，每位参与者的成本为 177 美元（BGC 承担 67 美元的费用；为资助 GTO 的实体支付 110 美元）。这些结果对 CHOICE 每年提供的次数的假设最为敏感。为 CHOICE 添加 GTO 实施支持将每位参与者的成本增加了约 150 美元。为了支付这笔额外的费用，有证据表明，在为期 2 年的干预结束后，CHOICE 计划以更高的保真度提供，并更频繁地提供。如果发现这种更好和持续的实施的长期效益超过了这些额外的成本，那么 GTO 可以成为支持基于证据的药物滥用预防计划的有吸引力的结构。试验注册。本项目在 ClinicalTrials.gov 注册，编号为 NCT02135991（网址：https://clinicaltrials.gov/show/NCT02135991）。该试验于 2014 年 5 月 12 日注册。
